Florida Company Sells Teenage Blood to Consumers Willing to Pay
"blood donors range in age from 16 to 25, while patients fall into the over 30's bracket"
"Because blood transfusions are already approved by the Food and Drug Administration, Ambrosia's approach has the green-light to continue as an off-label treatment."
Is Young Blood The Secret To Eternal Youth?
Mercury News 1/17/2019: Blood from the young now on sale for the old in San Francisco: report
Stanford-educated founder’s treatment intended to fight aging
You don’t have to drink the blood of children to reclaim the vigor of your lost youth. You can mainline it. For $8,000 a liter.
Ambrosia, a startup founded by a Stanford Medical School graduate, has begun pouring the blood of the young into the hardened arteries of their elders in five cities, one of them San Francisco, according to a new report.
Founded in 2016 by Jesse Karmazin, an MD never licensed to practice medicine, Florida-based Ambrosia claims to be able to combat aging through infusions of blood plasma from younger people.
https://www.mercurynews.com/2019/01/17/blood-from-the-young-now-on-sale-for-the-old-in-san-francisco-report/
_______________
Florida Company Opens Clinics Across America as Elite Line Up to Pay $8000 a Liter to Ingest Young Blood
DC Clothesline 1/21/2019: The blood donors range in age from 16 to 25, while patients fall into the over 30s bracket. So far, roughly 150 patients aged 35 to 92 have reportedly undergone the “young plasma treatments,” and the company claims a waiting list has already formed.
https://www.dcclothesline.com/2019/01/21/florida-company-opens-clinics-across-america-as-elite-line-up-to-pay-8000-a-liter-to-ingest-young-blood/
_______________
BIZ INSIDER 9/24/2018: A controversial startup that charges $8,000 to fill your veins with young blood is opening its first clinic.
"While the results of that study have not yet been made public, Karmazin told Business Insider the results were "really positive."
"Because blood transfusions are already approved by the Food and Drug Administration, Ambrosia's approach has the green-light to continue as an off-label treatment."
https://www.businessinsider.com/young-blood-transfusions-launching-first-clinic-new-york-2018-9
_______________
SCIENCE MAG 8/5/2016: Antiaging trial using young blood stirs concerns
Summary: The first-ever clinical trial in the United States to test the antiaging benefits of an unusual therapy—plasma from young donors—in relatively healthy people is getting underway this month. The trial was inspired in part by a 2014 study finding that injecting old mice with the plasma portion of blood from young mice seemed to improve the elderly rodents' memory and ability to learn. But there's a big caveat: The company, Ambrosia, plans to charge participants $8000 for lab tests and a one-time treatment. To some ethicists and researchers, the trial raises red flags, both for its cost to participants and for a design that they say is unlikely to deliver much science.
http://science.sciencemag.org/content/353/6299/527
_______________
Tranfusion Therapy Not to Be Confused with Adrenochrome Consumption
WIKIPEDIA: Adrenochrome Effect on the brain: "Several small-scale studies (involving 15 or fewer test subjects) conducted in the 1950s and 1960s reported that adrenochrome triggered psychotic reactions such as thought disorder, derealization, and euphoria.[2] Researchers Abram Hoffer and Humphry Osmond claimed that adrenochrome is a neurotoxic, psychotomimetic substance and may play a role in schizophrenia and other mental illnesses."
https://en.wikipedia.org/wiki/Adrenochrome
# # # #